Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Amortization - Intangibles (2020 - 2025)

Historic Amortization - Intangibles for Haemonetics (HAE) over the last 6 years, with Q4 2025 value amounting to $10.9 million.

  • Haemonetics' Amortization - Intangibles fell 1060.51% to $10.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $44.8 million, marking a year-over-year decrease of 545.9%. This contributed to the annual value of $48.3 million for FY2025, which is 5066.97% up from last year.
  • Haemonetics' Amortization - Intangibles amounted to $10.9 million in Q4 2025, which was down 1060.51% from $11.2 million recorded in Q3 2025.
  • Over the past 5 years, Haemonetics' Amortization - Intangibles peaked at $12.5 million during Q2 2024, and registered a low of $6.9 million during Q4 2023.
  • Moreover, its 5-year median value for Amortization - Intangibles was $11.1 million (2025), whereas its average is $10.1 million.
  • Per our database at Business Quant, Haemonetics' Amortization - Intangibles tumbled by 3351.99% in 2022 and then soared by 7696.43% in 2024.
  • Over the past 5 years, Haemonetics' Amortization - Intangibles (Quarter) stood at $11.4 million in 2021, then fell by 29.14% to $8.1 million in 2022, then dropped by 14.45% to $6.9 million in 2023, then surged by 76.96% to $12.2 million in 2024, then fell by 10.61% to $10.9 million in 2025.
  • Its Amortization - Intangibles was $10.9 million in Q4 2025, compared to $11.2 million in Q3 2025 and $11.4 million in Q2 2025.